2011•Chinese Journal of Drug Application and MonitoringRequires access

Bioequivalence of lovastatin capsules in healthy volunteers

Dan Liu

Open publisher page 0 citations

Abstract

Objective: To evaluate the bioequivalence of two different lovastatin capsules in healthy volunteers.Methods:The whole blood concentrations of lovastatin in 20 male healthy volunteers taking orally tested and reference preparations after a single dose were determined by LC/MS/MS.The pharmacokinetic parameters were calculated by DAS2.1 software.Results:The main pharmacokinetic parameters of two lovastatin capsules were as follows:t1/2 were(4.67±2.34) and(5.30±2.62) h;tmax were(1.90±0.50) and(2.13±0.39) h;Cmax were(8.37±0.84) and(8.29±1.00) ng·mL-1;AUC0-t were(32.25±6.49)and(32.71±7.59) ng·h·mL-1;AUC0-∞ were(33.62±6.94) and(34.71±8.62) ng·h·mL-1.The relative bioavailability of test preparation was(99.60±8.30)%.Conclusion:The tested preparation was bioequivalent to the reference preparation.

About this research paper

What this paper is about

Objective: To evaluate the bioequivalence of two different lovastatin capsules in healthy volunteers.Methods:The whole blood concentrations of lovastatin in 20 male healthy volunteers taking orally tested and reference preparations after a single dose were determined by LC/MS/MS.The pharmacokinetic parameters were calculated by DAS2.1 software.Results:The main pharmacokinetic parameters of two lovastatin capsules were as follows:t1/2 were(4.67±2.34) and(5.30±2.62) h;tmax were(1.90±0.50) and(2.13±0.39) h;Cmax were(8.37±0.84) and(8.29±1.00) ng·mL-1;AUC0-t were(32.25±6.49)and(32.71±7.59) ng·h·mL-1;AUC0-∞ were(33.62±6.94) and(34.71±8.62) ng·h·mL-1.The relative bioavailability of test preparation was(99.60±8.30)%.Conclusion:The tested preparation was bioequivalent to the reference preparation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the bioequivalence of two different lovastatin capsules in healthy volunteers.Methods:The whole blood concentrations of lovastatin in 20 male healthy volunteers taking orally tested and reference preparations after a single dose were determined by LC/MS/MS.The pharmacokinetic parameters were calculated by DAS2.1 software.Results:The main pharmacokinetic parameters of two lovastatin capsules were as follows:t1/2 were(4.67±2.34) and(5.30±2.62) h;tmax were(1.90±0.50) and(2.13±0.39) h;Cmax were(8.37±0.84) and(8.29±1.00) ng·mL-1;AUC0-t were(32.25±6.49)and(32.71±7.59) ng·h·mL-1;AUC0-∞ were(33.62±6.94) and(34.71±8.62) ng·h·mL-1.The relative bioavailability of test preparation was(99.60±8.30)%.Conclusion:The tested preparation was bioequivalent to the reference preparation.

Key concepts: Bioequivalence, Lovastatin, Medicine, Cmax, Pharmacokinetics, Bioavailability, Pharmacology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of lovastatin capsules in healthy volunteers — Research Paper | ScholarLens